CONCLUSIONS
SARS-CoV-2 has major implications for the cardiovascular system. Given the decrease in new Covid-19 cases worldwide, now we are approaching the so-called “Phase 2” challenge of a gradual return to pre-Covid-19 life. The epidemiological and clinical situation is rapidly evolving and practice patterns with policies depend on institutions and local availability. We expect a continue and progressive update of the recommendations, which serve as general framework in cardiac patients.
REFERENCES
1. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).JAMA Cardiol . 2020. doi:10.1001/jamacardio.2020.1017
2. Stefanini GG, Azzolini E, Condorelli G. Critical organizational issues for cardiologists in the COVID-19 outbreak: A frontline experience from Milan, Italy. Circulation . 2020. doi:10.1161/circulationaha.120.047070
3. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19.N Engl J Med . 2020. doi:10.1056/NEJMp2003539
4. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
5. ASE Statement on COVID-19. https://www.asecho.org/ase-statement-covid-19/